Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity-Reference-Cited by-同舟云学术

Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity

Published:2019-02-05 Issue:5 Volume:62 Page:2750-2771
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Sniecikowska Joanna¹^ORCID,Gluch-Lutwin Monika¹,Bucki Adam¹^ORCID,Więckowska Anna¹^ORCID,Siwek Agata¹,Jastrzebska-Wiesek Magdalena¹,Partyka Anna¹,Wilczyńska Daria¹,Pytka Karolina¹,Pociecha Krzysztof¹,Cios Agnieszka¹,Wyska Elżbieta¹,Wesołowska Anna¹,Pawłowski Maciej¹,Varney Mark A.²,Newman-Tancredi Adrian²^ORCID,Kolaczkowski Marcin¹^ORCID

Affiliation:

1. Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Kraków, Poland

2. Neurolixis Inc., 34145 Pacific Coast Highway #504, Dana Point, 92629 California, United States

Funder

Narodowe Centrum Nauki

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00062

Reference100 articles.